Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.9 HKD | -2.55% | -10.55% | +9.57% |
May. 14 | Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise | MT |
May. 14 | Everest Medicines Announces Commercial Launch and First Prescription for NEFECON in Mainland China | CI |
End-of-day quotes
Sector Biopharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
965M | - | |||||
89.69B | ||||||
41.34B | ||||||
33.72B | ||||||
26.11B | ||||||
14.63B |